Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Effect of Influenza Vaccination of Children on Infection Rate in Hutterite Communities: Follow-Up Study of a Randomized Trial.

Wang B, Russell ML, Moss L, Fonseca K, Earn DJ, Aoki F, Horsman G, Caeseele PV, Chokani K, Vooght M, Babiuk L, Webby R, Walter SD, Loeb M.

PLoS One. 2016 Dec 15;11(12):e0167281. doi: 10.1371/journal.pone.0167281. eCollection 2016.

2.

Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America.

Olivera-Botello G, Coudeville L, Fanouillere K, Guy B, Chambonneau L, Noriega F, Jackson N; CYD-TDV Vaccine Trial Group.

J Infect Dis. 2016 Oct 1;214(7):994-1000. doi: 10.1093/infdis/jiw297. Epub 2016 Jul 14.

3.

Cost Effectiveness of Influenza Vaccine Choices in Children Aged 2-8 Years in the U.S.

Smith KJ, Raviotta JM, DePasse JV, Brown ST, Shim E, Patricia Nowalk M, Zimmerman RK.

Am J Prev Med. 2016 May;50(5):600-8. doi: 10.1016/j.amepre.2015.12.010. Epub 2016 Feb 8.

4.

Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011-12 through 2013-14 influenza seasons.

Kahn KE, Santibanez TA, Zhai Y, Singleton JA.

Vaccine. 2015 Sep 22;33(39):5196-203. doi: 10.1016/j.vaccine.2015.07.064. Epub 2015 Aug 1.

5.

Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment.

Andersohn F, Bornemann R, Damm O, Frank M, Mittendorf T, Theidel U.

GMS Health Technol Assess. 2014 Oct 30;10:Doc03. doi: 10.3205/hta000119. eCollection 2014.

6.

Timeliness of pediatric influenza vaccination compared with seasonal influenza activity in an urban community, 2004-2008.

Hofstetter AM, Natarajan K, Rabinowitz D, Martinez RA, Vawdrey D, Arpadi S, Stockwell MS.

Am J Public Health. 2013 Jul;103(7):e50-8. doi: 10.2105/AJPH.2013.301351. Epub 2013 May 16.

7.

Effectiveness of seasonal influenza vaccines in children -- a systematic review and meta-analysis.

Lukšić I, Clay S, Falconer R, Pulanic D, Rudan I, Campbell H, Nair H.

Croat Med J. 2013 Apr;54(2):135-45. Review.

8.

An approximation of herd effect due to vaccinating children against seasonal influenza - a potential solution to the incorporation of indirect effects into static models.

Van Vlaenderen I, Van Bellinghen LA, Meier G, Nautrup BP.

BMC Infect Dis. 2013 Jan 22;13:25. doi: 10.1186/1471-2334-13-25.

9.

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults.

Ambrose CS, Levin MJ, Belshe RB.

Influenza Other Respir Viruses. 2011 Mar;5(2):67-75. doi: 10.1111/j.1750-2659.2010.00183.x. Epub 2010 Nov 19. Review.

10.

The population impact of a large school-based influenza vaccination campaign.

Grijalva CG, Zhu Y, Simonsen L, Mitchel E, Griffin MR.

PLoS One. 2010 Nov 30;5(11):e15097. doi: 10.1371/journal.pone.0015097.

11.

Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials.

Mallory RM, Malkin E, Ambrose CS, Bellamy T, Shi L, Yi T, Jones T, Kemble G, Dubovsky F.

PLoS One. 2010 Oct 29;5(10):e13755. doi: 10.1371/journal.pone.0013755.

12.

Establishing the baseline burden of influenza in preparation for the evaluation of a countywide school-based influenza vaccination campaign.

Grijalva CG, Zhu Y, Simonsen L, Griffin MR.

Vaccine. 2010 Dec 10;29(1):123-9. doi: 10.1016/j.vaccine.2010.08.072. Epub 2010 Nov 2.

13.

Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants.

Glezen WP, Gaglani MJ, Kozinetz CA, Piedra PA.

J Infect Dis. 2010 Dec 1;202(11):1626-33. doi: 10.1086/657089. Epub 2010 Oct 28.

14.

Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age.

Belshe RB, Toback SL, Yi T, Ambrose CS.

Influenza Other Respir Viruses. 2010 May 1;4(3):141-5. doi: 10.1111/j.1750-2659.2009.00124.x.

15.

Impact of a school-based influenza immunization program on disease burden: comparison of two Tennessee counties.

Poehling KA, Talbot HK, Williams JV, Zhu Y, Lott J, Patterson L, Edwards KM, Griffin MR.

Vaccine. 2009 May 5;27(20):2695-700. doi: 10.1016/j.vaccine.2009.02.043. Epub 2009 Feb 24.

16.

Evidence of effectiveness from a large county-wide school-based influenza immunization campaign.

Grijalva CG, Zhu Y, Griffin MR.

Vaccine. 2009 May 5;27(20):2633-6. doi: 10.1016/j.vaccine.2009.02.039. Epub 2009 Feb 24.

17.

Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons.

Eisenberg KW, Szilagyi PG, Fairbrother G, Griffin MR, Staat M, Shone LP, Weinberg GA, Hall CB, Poehling KA, Edwards KM, Lofthus G, Fisher SG, Bridges CB, Iwane MK; New Vaccine Surveillance Network.

Pediatrics. 2008 Nov;122(5):911-9. doi: 10.1542/peds.2007-3304.

18.

Vaccines to prevent pneumonia and improve child survival.

Madhi SA, Levine OS, Hajjeh R, Mansoor OD, Cherian T.

Bull World Health Organ. 2008 May;86(5):365-72.

19.

Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.

Halloran ME, Piedra PA, Longini IM Jr, Gaglani MJ, Schmotzer B, Fewlass C, Herschler GB, Glezen WP.

Vaccine. 2007 May 16;25(20):4038-45. Epub 2007 Mar 12.

Supplemental Content

Support Center